Emma Rose Gregg, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3501 Dunn Rd Ste 108, Florissant, MO 63033 Phone: 314-972-8070 |
Ms. Mandy E Collins, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15955 New Halls Ferry Rd, Florissant, MO 63031 Phone: 314-953-4950 |
Mr. Erik Anthony Judson, M.O.T., OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 790 N Highway 67, Florissant, MO 63031 Phone: 314-972-1442 |
Ms. Kaitlin K Field, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 15955 New Halls Ferry Rd, Florissant, MO 63031 Phone: 314-953-5000 |
Mary Whiteside, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3501 Dunn Rd, Suite 108, Florissant, MO 63033 Phone: 314-972-8070 |
Kaydee Alene Funkhouser, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 936 Charbonier Rd, Florissant, MO 63031 Phone: 314-831-4800 |
News Archive
Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.
Thyroid hormone deficiencies in early pregnancy can cause locomotor underdevelopment in the child, according to research from the Swedish medical university Karolinska Institutet.
New clues to why some kinds of leukemia are more aggressive and deadly than others are coming from research examining the types of genetic damage that allow some blood cells to grow out of control, scientists report.
There is now a new alternative to immunosuppressive treatment after kidney transplants which comes without the usual severe side effects. The Medical University was significantly involved in the clinical development of the active ingredient Belatacept and a suitable preparation has now been given EU-wide authorisation.
› Verified 3 days ago